Overview

Bone Mineral Density in Adults With Hyperphenylalaninemia on Kuvan Therapy

Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Prospective study to compare the bone mineral density in adults with HPA on KUVAN™ therapy to those not on therapy. The investigators hypothesize that after one year of KUVAN™ therapy, there will be an improvement in their bone mineral density.
Phase:
N/A
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborator:
BioMarin Pharmaceutical